Search research articles
Contact Us
Filters
Showing results (21-30 of 124) with videos related to
Page
of 13
Sort By:
JAMA Oncology
|
December 30, 2016
Making Molecular Imaging a Clinical Tool for Precision Oncology: A Review
David A Mankoff, Michael D Farwell, Amy S Clark, et al.
Cancer Journal (Sudbury, Mass.)
|
June 8, 2015
How Imaging Can Impact Clinical Trial Design: Molecular Imaging as a Biomarker for Targeted Cancer Therapy
David A Mankoff, Michael D Farwell, Amy S Clark, et al.
Seminars in Nuclear Medicine
|
December 22, 2015
Development of Companion Diagnostics
David A Mankoff, Christine E Edmonds, Michael D Farwell, et al.
Clinical Nuclear Medicine
|
August 22, 2006
I-123 MIBG scan of metastatic neuroblastoma mimicking a bone scan
Gregory Ravizzini, Daniel A Pryma, Gustavo S P Meirelles, et al.
The British Journal of Radiology
|
August 22, 2022
Total-body PET: a new paradigm for molecular imaging
Margaret E Daube-Witherspoon, Austin R Pantel, Daniel A Pryma, et al.
World Journal of Surgery
|
December 17, 2008
Sestamibi SPECT intensity scoring system in sporadic primary hyperparathyroidism
Linwah Yip, Daniel A Pryma, John H Yim, et al.
Expert Opinion on Drug Delivery
|
June 12, 2013
Targeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: crossing the blood-brain barrier divide
Ann-Marie Chacko, Chunsheng Li, Daniel A Pryma, et al.
American Journal of Clinical Oncology
|
November 1, 2012
Prognostic value of primary tumor FDG uptake for occult mediastinal lymph node involvement in clinically N2/N3 node-negative non-small cell lung cancer
Andrew D Trister, Daniel A Pryma, Eric Xanthopoulos, et al.
Journal of Endourology
|
May 20, 2008
Drainage characteristics and differential function of the horseshoe kidney: what is typical?
Benjamin R Stockton, Daniel A Pryma, Marc C Smaldone, et al.
Seminars in Radiation Oncology
|
November 28, 2020
Radiopharmaceutical Chemistry and Drug Development-What's Changed?
Charles A Kunos, David A Mankoff, Michael K Schultz, et al.
Page
of 13
Search research articles
Search
Showing results (21-30 of 124) with videos related to
Sort By:
Page
of 13
JAMA Oncology
|
December 30, 2016
Making Molecular Imaging a Clinical Tool for Precision Oncology: A Review
David A Mankoff, Michael D Farwell, Amy S Clark, et al.
Cancer Journal (Sudbury, Mass.)
|
June 8, 2015
How Imaging Can Impact Clinical Trial Design: Molecular Imaging as a Biomarker for Targeted Cancer Therapy
David A Mankoff, Michael D Farwell, Amy S Clark, et al.
Seminars in Nuclear Medicine
|
December 22, 2015
Development of Companion Diagnostics
David A Mankoff, Christine E Edmonds, Michael D Farwell, et al.
Clinical Nuclear Medicine
|
August 22, 2006
I-123 MIBG scan of metastatic neuroblastoma mimicking a bone scan
Gregory Ravizzini, Daniel A Pryma, Gustavo S P Meirelles, et al.
The British Journal of Radiology
|
August 22, 2022
Total-body PET: a new paradigm for molecular imaging
Margaret E Daube-Witherspoon, Austin R Pantel, Daniel A Pryma, et al.
World Journal of Surgery
|
December 17, 2008
Sestamibi SPECT intensity scoring system in sporadic primary hyperparathyroidism
Linwah Yip, Daniel A Pryma, John H Yim, et al.
Expert Opinion on Drug Delivery
|
June 12, 2013
Targeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: crossing the blood-brain barrier divide
Ann-Marie Chacko, Chunsheng Li, Daniel A Pryma, et al.
American Journal of Clinical Oncology
|
November 1, 2012
Prognostic value of primary tumor FDG uptake for occult mediastinal lymph node involvement in clinically N2/N3 node-negative non-small cell lung cancer
Andrew D Trister, Daniel A Pryma, Eric Xanthopoulos, et al.
Journal of Endourology
|
May 20, 2008
Drainage characteristics and differential function of the horseshoe kidney: what is typical?
Benjamin R Stockton, Daniel A Pryma, Marc C Smaldone, et al.
Seminars in Radiation Oncology
|
November 28, 2020
Radiopharmaceutical Chemistry and Drug Development-What's Changed?
Charles A Kunos, David A Mankoff, Michael K Schultz, et al.
Page
of 13